Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma – The SHELTER study
Bitzer, Michael, Horger, Marius, Giannini, Edoardo G., Ganten, Tom M., Wörns, Marcus A., Siveke, Jens T., Dollinger, Matthias M., Gerken, Guido, Scheulen, Max E., Wege, Henning, Zagonel, Vittorina, Cillo, Umberto, Trevisani, Franco, Santoro, Armando, Montesarchio, Vincenzo, Malek, Nisar P., Holzapfel, Julia, Herz, Thomas, Ammendola, Astrid S., Pegoraro, Stefano, Hauns, Bernhard, Mais, Anna, Lauer, Ulrich M., Henning, Stefan W., Hentsch, Bernd
Published in Journal of hepatology (01.08.2016)
Published in Journal of hepatology (01.08.2016)
Get full text
Journal Article
Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma
Ruf, Benjamin, Berchtold, Susanne, Venturelli, Sascha, Burkard, Markus, Smirnow, Irina, Prenzel, Tanja, Henning, Stefan W, Lauer, Ulrich M
Published in Molecular therapy. Oncolytics (2015)
Published in Molecular therapy. Oncolytics (2015)
Get full text
Journal Article
Resminostat in patients with relapsed or refractory Hodgkin lymphoma: results of the phase II SAPHIRE study
Walewski, Jan, Paszkiewicz-Kozik, Ewa, Borsaru, Gabriela, Hellmann, Andrzej, Janikova, Andrea, Warszewska, Agnieszka, Mais, Anna, Ammendola, Astrid, Herz, Thomas, Krauss, Babett, Henning, Stefan W.
Published in Leukemia & lymphoma (23.02.2019)
Published in Leukemia & lymphoma (23.02.2019)
Get full text
Journal Article
Toward Understanding the Mechanism of Chromophore-assisted Laser Inactivation—Evidence for the Primary Photochemical Steps
Horstkotte, Elke, Schröder, Torsten, Niewöhner, Jens, Thiel, Erwin, Jay, Daniel G., Henning, Stefan W.
Published in Photochemistry and photobiology (01.03.2005)
Published in Photochemistry and photobiology (01.03.2005)
Get full text
Journal Article
The GTPase Rho has a critical regulatory role in thymus development
Henning, Stefan W., Galandrini, Ricciarda, Hall, Alan, Cantrell, Doreen A.
Published in The EMBO journal (01.05.1997)
Published in The EMBO journal (01.05.1997)
Get full text
Journal Article
Functional proteomic screens reveal an essential extracellular role for hsp90α in cancer cell invasiveness
Jay, Daniel G, Eustace, Brenda K, Sakurai, Takashi, Stewart, Jean K, Yimlamai, Dean, Unger, Christine, Zehetmeier, Carol, Lain, Blanca, Torella, Claudia, Henning, Stefan W, Beste, Gerald, Scroggins, Bradley T, Neckers, Len, Ilag, Leodevico L
Published in Nature cell biology (01.06.2004)
Published in Nature cell biology (01.06.2004)
Get full text
Journal Article
Tu1875 Vidofludimus Induces p53-Mediated Apoptosis in Activated T Cells and Inhibits IL-17A and IL-17F Expression Decoupled From Lymphocyte Proliferation
Hamm, Svetlana, Henning, Stefan W, Hentsch, Bernd, Vitt, Daniel, Groeppel, Manfred, Ammendola, Aldo
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2012)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2012)
Get full text
Journal Article
356 Vidofludimus Inhibits Colonic IL-17 and Improves Hapten-Induced Colitis in Rats by a Unique Dual Mode of Action
Fitzpatrick, Leo R, Small, Jeffrey S, Doblhofer, Robert Y, Henning, Stefan W, Ammendola, Aldo
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2012)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2012)
Get full text
Journal Article
Different Functions of the GTPase Rho in Prothymocytes and Late Pre-T Cells
Galandrini, Ricciarda, Henning, Stefan W, Cantrell, Doreen A
Published in Immunity (Cambridge, Mass.) (01.07.1997)
Published in Immunity (Cambridge, Mass.) (01.07.1997)
Get full text
Journal Article
Toward Understanding the Mechanism of Chromophore-assisted Laser Inactivation-Evidence for the Primary Photochemical Steps
Horstkotte, Elke, Schröder, Torsten, Niewöhner, Jens, Thiel, Erwin, Jay, Daniel G., Henning, Stefan W.
Published in Photochemistry and photobiology (01.03.2005)
Published in Photochemistry and photobiology (01.03.2005)
Get full text
Journal Article
Emerging high-throughput drug target validation technologies
Ilag, Leodevico L., Ng, Jocelyn H., Beste, Gerald, Henning, Stefan W.
Published in Drug discovery today (15.09.2002)
Published in Drug discovery today (15.09.2002)
Get full text
Journal Article
Population PK/PD analysis of the pan-HDAC inhibitor resminostat
Baumgartner, Roland, Henning, Stefan W., Hauns, Bernhard, Ammendola, Astrid, Krauss, Babett, Holzapfel, Julia, Bitzer, Michael, Hentsch, Bernd
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Beyond the genome--SMi Conference 27-28 January 2003, London, UK
Swinton, Jonathan, Sheridan, Joe M, Henning, Stefan W
Published in IDrugs : the investigational drugs journal (01.03.2003)
Get more information
Published in IDrugs : the investigational drugs journal (01.03.2003)
Journal Article
Centralized analysis of phase II ECG dataset of resminostat, an orally available histone-deacetylase inhibitor (HDACi)
Hauns, Bernhard, Schulze-Bergkamen, Henning, Jaeger, Dirk, Kopp, Hans-Georg, Bitzer, Michael, Krauss, Babett, Henning, Stefan W., Hentsch, Bernd, Haverkamp, Wilhelm
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Resminostat in combination with sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER Study
Bitzer, Michael, Horger, Marius, Giannini, Edoardo G, Ganten, Tom M, Wörns, Marcus A, Siveke, Jens T, Dollinger, Matthias M, Gerken, Guido, Scheulen, Max E, Wege, Henning, Zagonel, Vittorina, Cillo, Umberto, Trevisani, Franco, Santoro, Armando, Montesarchio, Vincenzo, Malek, Nisar P, Holzapfel, Julia, Herz, Thomas, Ammendola, Astrid S, Pegoraro, Stefano, Hauns, Bernhard, Mais, Anna, Lauer, Ulrich M, Henning, Stefan W, Hentsch, Bernd
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Phase I dose escalation of the oral histone deacetylase inhibitor (HDACi) resminostat in combination with FOLFIRI in colorectal cancer (CRC) patients: The SHORE trial
Schulze-Bergkamen, Henning, Jaeger, Dirk, Kopp, Hans-Georg, Mayer, Frank, Bitzer, Michael, Mais, Anna, Resemann, Karin, Hauns, Bernhard, Asche, Julia, Henning, Stefan W., Hentsch, Bernd
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Final Results of the Phase II SAPHIRE Trial of Resminostat (4SC-201) in Patients with Relapsed/Refractory Hodgkin Lymphoma
Walewski, Jan, Paszkiewicz-Kozik, Ewa, Warszewska, Agnieszka, Borsaru, Gabriela, Moicean, Andreea, Hellmann, Andrzej, Mayer, Jiri, Hauns, Bernhard, Mais, Anna, Henning, Stefan W., Hentsch, Bernd
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Resminostat In Relapsed or Refractory Hodgkin Lymphoma: Initial Results of the SAPHIRE Phase II Trial with a Novel Oral Histone Deacetylase (HDAC) Inhibitor
Walewski, Jan, Paszkiewicz-Kozik, Ewa, Borsaru, Gabriela, Moicean, Andreea, Warszewska, Agnieszka, Strobel, Klaus, Biggi, Alberto, Hauns, Bernhard, Mais, Anna, Henning, Stefan W., Hentsch, Bernd
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article
The GTPase rho controls a p53-dependent survival checkpoint during thymopoiesis
Costello, P S, Cleverley, S C, Galandrini, R, Henning, S W, Cantrell, D A
Published in The Journal of experimental medicine (03.07.2000)
Published in The Journal of experimental medicine (03.07.2000)
Get full text
Journal Article